Summary
In 75 operatively proved cases of primary hyperparathyroidism (PH) mean systolic and diastolic blood pressure (BP) values were significantly higher pre- than postoperatively. There were 27 patients (36%) who showed hypertension before operation (systolic BP≧150 mm Hg, mean 169±20 mm Hg). In 20 of these the hypertension was reversible after successful treatment of PH, in seven cases elevated values persisted. The mean age of patients with persisting hypertension was significantly higher than the group with normalization of BP after operation (P<0.01). As far as clinical presentation of PH was concerned it were those cases with hypercalcaemic syndrome and with accidentally discovered hypercalcaemia who most often showed hypertension. In cases with recurrent urolithiasis and with osteitis fibrosa as leading symptoms there was no significant increase of hypertension as compared to the whole group. Because of the relatively high incidence of hypertension in PH this possibility should be taken into consideration in each diagnostic clarification of hypertensive patients.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Beern N, Gallegos I, Cohen A, Klein N, Sonnenblick R, Frishman W (1981) Efficiacy of sublingual nifedipine in the acute treatment of systemic hypertension. Chest 79:571
Belizan JM, Villar J, Pineda O, Gonzalez AE, Sainz E, Garrera G, Sibrian R (1983) Reduction of blood pressure with calcium supplementation in young adults. J Am Med Assoc 249:1161–1165
Blaustein MP (1977) Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am J Physiol 232:C 165-C 173
Blum M, Kirsten M, Worth MH jr (1977) Reversible hypertension: caused by hypercalcemia of hyperparathyroidism, vitamin D toxicity, and calcium infusion. J Am Med Assoc 237:262–263
Bressel M, Christensen P, Dorn G, Hagemann J, Josten K, Montz R (1978) Diagnostik des primären Hyperparathyreoidismus unter Berücksichtigung der Parathormonbestimmung im Halsvenenblut. Urologe A 17:29–33
Brinton GS, Jubiz W, Lagerquist LD (1975) Hypertension in primary hyperparathyroidism: the role of the renin-angiotensin system. J Clin Endocrinol Metab 41:1025–1029
Christensson T, Hellström K, Wengle B (1977) Blood pressure in subjects with hypercalcemia and primary hyperparathyroidism detected in a health screening programme. Eur J Clin Invest 7:109–113
Daniels J, Goodman AD (1983) Hypertension and hyperparathyroidism. Inverse relation of serum phosphate level and blood pressure. Am J Med 75:17–20
Dyckner T, Wester PO (1983) Effect of magnesium on blood pressure. Br Med J 286:1847–1849
Earll JM, Kurtzmann NA, Moser RH (1966) Hypercalcemia and hypertension. Ann Intern Med 64:378–381
Gould BA, Hornung RS, Mann S, Balasubramanian V, Raftery EB (1982) Slow channel inhibitors verapamil and nifedipine in the management of hypertension. J Cardiovasc Pharmacol 4:369–373
Hehrmann R (1980) Plasma-Parathormon: Methodik, Pathophysiologie and Klinik. Urban und Schwarzenberg, Wien München Baltimore
Hellström J, Birke G, Edvall CA (1958) Hypertension in hyperparathyroidism. Br J Urol 30:13–24
Hesch RD (1980) Extraglanduläre Ursachen des Hyperparathyreoidismus. Dtsch Med Wochenschr 105:448–450
Kesteloot H, Geboers J (1982) Calcium and blood pressure. Lancet 1:813–815
Klein W, Mlekusch E, Härringer M (1982) Kalziumantagonisten zur Behandlung der chronischen arteriellen Hypertonie. Herz/Kreislauf 14:247–255
Kuhlencordt F, Lozano-Tonkin C (1964) Die Klinik des Hyperparathyreoidismus. Internist (Berl) 5:197–206
Losse H, Zidek W, Dorst KG, Vetter H, Zumkley H (1982) Die Bedeutung der intrazellulären Elektrolyte bei der arteriellen Hypertonie. Herz/Kreislauf 14:27–32
Massry SG, Weidmann P, Llach F (1977) Blood calcium levels and hypertension. Contrib Nephrol 18:117–125
McCarron DA (1983) Calcium and magnesium nutrition in human hypertension. Ann Intern Med 98:800–805
Paloyan E, Forland M, Pickleman JR (1969) Hyperparathy-roidism coexisting with hypertension and prolonged thiazide administration. Am J Med Assoc 210:1243–1245
Ringe J-D, Kuhlencordt F (1980) Ostitis fibrosa generalisata. In: Kuhlencordt F, Barthelheimer H (eds) Handbuch der inneren Medizin vol vI/1B. Springer, Berlin Heidelberg New York, pp 821–901
Ringe J-D, Runge M, Rehpenning W, Kuhlencordt F (1982) Hyperkalzämie und Ekg. Analyse der QT-Zeiten und Rhythmusstörungen bei 93 Patienten mit primärem Hyperparathyreoidismus. Herz/Kreislauf 14:179–184
Rosenthal FD, Roy S (1972) Hypertension and hyperparathyroidism. Br Med J 4:396–397
Scholz DA (1977) Hypertension and hyperparathyrodism. Arch Intern Med 137:1123–1124
Smith JM, Mouw DR Vander AJ (1979) Effect of parathy-roid hormone on plasma renin activity and sodium excretion. Am J Physiol 236:311–319
Thibonnier M, Corvol P, Banzet O, Menard J (1982) Acute antihypertensive and hormonal effects of a calcium antagonist in essential hypertension. J Cardiovasc Pharmacol 4:335–339
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ringe, J.D. Reversible hypertension in primary hyperparathyroidism — Pre-and posteroperative blood pressure in 75 cases. Klin Wochenschr 62, 465–469 (1984). https://doi.org/10.1007/BF01726908
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01726908